Doloracin/L with Lidocaine and Ranibizumab ophthalmic
Determining the interaction of Doloracin/L with Lidocaine and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: capsaicin / lidocaine / menthol / methyl salicylate topical
Brand name: LidoPro, Terocin, Transderm-iQ
Synonyms: Capsaicin, lidocaine, menthol, and methyl salicylate (topical)
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Doloracin/L with Lidocaine-Ranitidine
- Doloracin/L with Lidocaine-Ranitidine Capsule
- Doloracin/L with Lidocaine-Ranitidine Hydrochloride
- Doloracin/L with Lidocaine-Ranitidine Injection
- Doloracin/L with Lidocaine-Ranitidine Suspension
- Doloracin/L with Lidocaine-Ranitidine Syrup
- Ranibizumab ophthalmic-Dolorex
- Ranibizumab ophthalmic-Dolorex Forte
- Ranibizumab ophthalmic-Dolotranz
- Ranibizumab ophthalmic-Dolutegravir
- Ranibizumab ophthalmic-Dolutegravir 10 mg
- Ranibizumab ophthalmic-Dolutegravir 25 mg and 50 mg